US OptionsDetailed Quotes
AKYA241220P7500
- 0.00
- 0.000.00%
15min DelayClose Nov 22 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-255.45%PremiumDec 20, 2024Expiry Date5.39Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Akoya Biosciences Stock Discussion
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Akoya Biosciences (NASDAQ: AKYA) announces major innovations in spatial biology research at SITC 2024, introducing the PhenoCode Discovery IO60 panel and Mouse FFPE IO panel. The IO60 panel features 60 tumor and immunology markers, enabling comprehensive immune cell analysis with industry-leading throughput of over 16 samples per week. The ...
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
$Biora Therapeutics (BIOR.US)$
$Akoya Biosciences (AKYA.US)$
$Tharimmune (THAR.US)$
$Bit Brother (BETS.US)$
And they also announced that they have deployed MaxFuse Algorithm! Developed by Dr Garry Nolan at Stamford University for Multiomic Integration of Spatial and Single-Cell Data on the Enable Medicine Platform
No comment yet